Clinical Laboratory Services | Innovative Biomarker and Bioanalytical Solutions

Improving the quality of human health

Our services

About Synexa Life Sciences

Synexa Life Sciences is a leading provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays.  

With a team of over 200 staff across five global laboratory locations; Cape Town, London, Manchester, Berlin and Turku (Finland), we provide innovative solutions to support our customers achieve their clinical milestones.   

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies.  

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.  

Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions. 

Discover Synexa

Our Services

Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

Biomarkers

With decades of experience in biomarker strategies and assay development, our biomarker panels enhance decision-making in all stages of therapeutic clinical development.

Clinical Bioanalysis

We offer extensive experience in large molecule bioanalysis, developing and fully validating bespoke assays to support clinical sample analysis.

Radiopharmaceutical Bioanalysis

For over 15 years, our GMP and GLP-accredited facility in Turku, Finland, has supported radiopharmaceutical development with comprehensive radiobiological services.

Translational

Translational services are dedicated to understanding candidate therapeutics and generating clinically relevant data using fresh human samples from both healthy and diseased populations.

Flow Cytometry

Flow Cytometry is core to Synexa’s positioning as a biomarker expert. We provide key expertise in the development and validation of complex assays, encompassing multimer staining, phospho-flow and target engagement assays.

Proteomics

Offering unparalleled precision and sensitivity, Olink Target is a leading platform designed to propel your protein biomarker discovery research forward.

Tissue Imaging

Synexa’s specialised tissue and cell imaging services allow for the interrogation of multiple targets in situ. Leveraging cutting edge technologies, we provide comprehensive and precise insights into spatial relationships in cells and tissues.

Genomics

Synexa’s dedicated Genomics team specialises in developing bespoke, precise and robust assays that propel clinical research forward.

Biomarker Consulting

Leverage our expert team of in-house scientists to develop and implement optimal biomarker strategies. Integrative biomarker panels will provide crucial insights, improving the decision making process throughout clinical development of a therapeutic.

ELISpot Assay Services

The ELISpot assay precisely detects and quantifies antigen-specific immune responses at the single-cell level, providing insights into immune activity across various disease settings.

Discover Our Advanced Biomarker and Bioanalytical Solutions

Discover all services

Expertise

0105

Autoimmune

Synexa specialises in biomarker and bioanalytical services which can be specifically tailored to suit both the modality of the therapeutic and the disease area of focus. Autoimmune conditions are highly heterogenous, affecting numerous cell types, molecular pathways and tissues, necessitating multi-pronged approaches integrating technology platforms including targeted genetic analysis, soluble biomarkers and flow cytometry.

Learn more

Autoimmune

01

0205

Oncology

Synexa’s expertise in the field of immunology and immune-based analytical technologies makes us the perfect partner in advancing oncology therapeutic pipelines. We use innovative approaches and validated platforms to answer client-specific questions for quality, clinically-relevant data.
Learn more

Oncology

02

0305

Vaccines

Accelerate vaccine development and evaluation with our comprehensive suite of bioanalytical services, supporting safety, immunogenicity, and efficacy assessments for a wide range of vaccine candidates.
Learn more

Vaccines

03

0405

Cell & Gene Therapy

Advanced bioanalytical solutions for cell and gene therapies, providing comprehensive characterization, quantification, and safety assessment to support the development of innovative treatment approaches.

Cell & Gene Therapy

04

0505

Biosimilars

Robust analytical solutions for biosimilar development, offering comparative bioanalysis, potency assays, and structural characterization to ensure similarity to reference biologics and meet regulatory requirements.
Learn more

Biosimilars

05

Latest Insights

Video

Synexa Life Sciences Achieves Gyrolab CRO Certification

We are proud to announce that Synexa Life Sciences has been awarded Gyrolab CRO certification, recognising our expertise in advanced…
11 Jun, 2025 |  News
Read more

Video

Synexa Life Sciences Partners with Waters to Trial Xevo TQ Absolute XR Mass Spectrometer

Synexa Life Sciences is pleased to announce its collaboration with Waters Corporation as one of the first bioanalytical laboratories to…
10 Jun, 2025 |  News
Read more

Video

Claire Wildgoose Appointed General Manager of Synexa Life Sciences – UK

Synexa Life Sciences is excited to welcome Claire Wildgoose as General Manager - UK, following the acquisition of Alderley Analytical…
11 Feb, 2025 |  News
Read more
View more

Bridging the gap between science and life.

Discuss real solutions to develop your therapeutic pipeline.

Let’s get started